Want to stay on top of the science and politics driving biotech today? Sign up to get our biotech newsletter in your inbox. Morning. The ...

AstraZeneca’s planned vaccine hub for Liverpool is off the table - business editor Karl Matchett and Whitehall editor Kate ...

In November 2023, AstraZeneca proposed a major expansion of its vaccine plant in Speke, a move that would "bolster" Britain's ...

A pharma industry group asked the FDA to "take action" against a "dangerous" ad Hims & Hers plans to run during the Super ...

AstraZeneca unveiled both its fourth-quarter and full-year 2024 results before market open today, revealing that its total revenue was $14.89 billion. This represented a meaty 24% improvement over Q4 ...

Absci Corporation’s ABSI share price has surged by 17.57%, which has investors questioning if this is right time to sell.

Receive News & Ratings for Absci Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Absci and related companies with MarketBeat ...

Temperatures will be a touch milder Friday afternoon and into the weekend but will fall a few degrees early next week and through the remainder of the week. On Wednesday morning, Global BC ...

Feb. 6, 2025 — New research finds some baleen whale species call at such deep frequencies that they're completely undetectable by killer whales, which cannot hear sounds below 100 hertz. These ...

Jan. 31, 2025 — It's well known that consuming sugary drinks increases the risk of diabetes, but the mechanism behind this relationship is unclear. Now researchers show that metabolites produced ...

Prince Harry and his legal team arrived at a last-minute agreement with Rupert Murdoch’s British newspaper group on Tuesday in connection with a lawsuit accusing the publisher of extensive ...

Analyst Praises AMD-Partner Absci's Practical Approach, Sees 118% Stock Upside Needham analyst has initiated coverage on Absci Corporation (NASDAQ:ABSI), a drug and target discovery company that ...